Beutel, Goodman & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Beutel, Goodman & Co's LLY Position: Q2 2019 in Review
Beutel, Goodman & Co sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 264,854 shares — an estimated $25.7M sold.
Beutel, Goodman & Co first reported a position in LLY in Q3 2014 and held it in 14 quarters. The position peaked at $184M in Q3 2018. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.
- Beutel, Goodman & Co reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
- Beutel, Goodman & Co sold 264,854 Eli Lilly shares in Q2 2019, an estimated $25.7M.
- Beutel, Goodman & Co first reported a position in Eli Lilly in Q3 2014 and held it in 14 quarters.
- Beutel, Goodman & Co's Eli Lilly position peaked at $184M in Q3 2018.
- 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.
Based on Beutel, Goodman & Co's 13F filing for Q2 2019, filed 15 Aug 2019.